[ad_1] 18/07/2018 The State Institute for Drug Control (ŠÚKL) ordered the withdrawal from the Slovak market of medicines containing the active ingredient valsartan. This is due to the presence of undeclared impurities …
Read More »Sales withdraw drugs for heart problems: They contain a substance that they suspect of cancer
